Optimization management of internal mammary lymph node in breast cancer
10.3760/cma.j.cn115807-20231116-00154
- VernacularTitle:乳腺癌内乳淋巴结优化处理研究进展
- Author:
Zhao BI
1
;
Yongsheng WANG
Author Information
1. 山东省肿瘤防治研究院 山东第一医科大学 山东省医学科学院，济南 250117
- Keywords:
Breast cancer;
Internal mammary lymph node;
Sentinel lymph node biopsy;
Radiotherapy;
Neoadjuvant therapy.
- From:
Chinese Journal of Endocrine Surgery
2024;18(5):605-608
- CountryChina
- Language:Chinese
-
Abstract:
Internal mammary lymph node (IMLN) and axillary lymph node are the first station for breast cancer metastasis. The status of IMLN is one of the prognostic factors in breast cancer patients and essential to regional staging and adjuvant treatment choice. The axillary treatment of breast cancer has become to be individualized. The minimally invasive diagnosis and precise management of internal mammary region received attention again with the improvements in optimal systemic therapy and precision radiotherapy. In the era of sentinel lymph node biopsy, we need to accurately measure the treatment intensity required by patients and establish an individualized IMLN treatment strategy, in order to achieve the purpose of accurate treatment of regional lymph nodes in breast cancer. This review evaluated the latest progress of precise regional processing of IMLN, in order to provide reference for clinical doctors.
